Armata Pharmaceuticals (United States)
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on developing pathogen-specific bacteriophage therapeutics for antibiotic-resistant infections.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections. The company is headquartered in Los Angeles, California, in a 56,000 square foot facility built for phage product development with capabilities spanning bench to clinic.
History
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections. The company is headquartered in Los Angeles, California, in a 56,000 square foot facility built for phage product development with capabilities spanning bench to clinic. Deborah Birx, M.D., was appointed Chief Executive Officer of Armata on July 10, 2023.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/armata-pharmaceuticals-united-states · Editorial policy · How profiles are compiled